Literature DB >> 7316853

Carcinoma of the tonsil. Analysis of 162 cases.

C D Givens, M E Johns, R W Cantrell.   

Abstract

The treatment of 162 patients with squamous cell carcinoma of the tonsil seen at the University of Virginia Medical Center, Charlottesville, from 1955 through 1974 was reviewed. One hundred four patients form the basis of this report. The patients were grouped by the stage of disease, and then three- and five-year determinate survival, recurrences, distant metastases, and complications were examined. The treatment used was surgery, radiation, or a combination of preoperative radiation and surgery. The overall five-year determinate survival for stage I was 93.3%; stage II, 57%; stage III, 27%; and stage IV, 17%. The five-year determinate survivals of patients treated with surgery alone, radiation, and combination therapy were 88%, 27%, and 32%, respectively. The latter two treatment modalities were biased by a greater proportion of patients with stage III and IV disease, whereas surgery alone included a high proportion of patients with stage I and II disease. Based on this review and those reported in the literature, we recommend radical radiation therapy for stage I and II disease and combination radiation therapy and composite resection for stages III and IV.

Entities:  

Mesh:

Year:  1981        PMID: 7316853     DOI: 10.1001/archotol.1981.00790480006002

Source DB:  PubMed          Journal:  Arch Otolaryngol        ISSN: 0003-9977


  4 in total

1.  Radiotherapy alone or combined with chemotherapy as definitive treatment for squamous cell carcinoma of the tonsil.

Authors:  William R Kennedy; Michael P Herman; Rohan L Deraniyagala; Robert J Amdur; John W Werning; Peter Dziegielewski; Jessica Kirwan; Christopher G Morris; William M Mendenhall
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-04-08       Impact factor: 2.503

2.  Trismus and carcinoma of the tonsil.

Authors:  S Kristensen; K Tveterås
Journal:  Arch Otorhinolaryngol       Date:  1984

Review 3.  HPV infections and tonsillar carcinoma.

Authors:  S Syrjänen
Journal:  J Clin Pathol       Date:  2004-05       Impact factor: 3.411

4.  Tonsillar carcinoma.

Authors:  M E Guay; P Lavertu
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.